Tolmar is a specialty pharmaceutical company that focuses on developing innovative treatments in urology, oncology, and endocrinology. The company is dedicated to addressing unmet patient needs by enhancing medication compliance and increasing the bioavailability of their long-acting injectable therapies. Tolmar's fully integrated operations in the United States encompass all phases of the product lifecycle, from research and development to manufacturing and commercialization. This comprehensive approach allows them to create and deliver specialized treatments that improve patient experiences and outcomes.

The company emphasizes a patient-first mentality, driving their research and development efforts to identify and solve real-world clinical challenges. Tolmar's robust R&D pipeline enables them to explore new solutions and improve existing therapies, ensuring that their products meet the evolving needs of patients and healthcare providers. Their commitment to innovation is reflected in their ability to streamline treatment processes, such as transforming dual syringe systems into single pre-connected syringes for enhanced patient comfort. Through their extensive capabilities, Tolmar aims to deliver life-changing treatments and maintain a strong presence in the global pharmaceutical market.

United States

Tolmar is a Northern Colorado based pharmaceutical research, development, manufacturing and commercial operations company. Tolmar develops and manufactures both proprietary and generic pharmaceutical products with specific focus in dermatology, oncology, and specialty injectable therapeutic areas.

Tolmar

Company Details